Valeant, Allergan and Ackman: overview from ChatGPT www.reuters.com In 2014, Valeant Pharmaceuticals International made an unsolicited bid to acquire Allergan, a company specializing in aesthetic medicine, for $47 billion. Allergan rejecte…
Quote saved.
Login to quote this blog
Failed to save quote. Please try again later.
You cannot quote because this article is private.
